HuR (ELAVL1) Stabilizes SOX9 mRNA and Promotes Migration and Invasion in Breast Cancer Cells
Cancers · 16.01.2024 · 16 (2) · 384
DOI: 10.3390/cancers16020384 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 16.01.2024. Verfasst von Jesús Morillo-Bernal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Bioquímica UAM, Instituto de Investigaciones Biomédicas Sols-Morreale, CSIC-UAM, 28029 Madrid, Spain. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish Ministry of Science and Innovation SAF2016-76504-R (A.C. and F.P.), EU-FEDER funds.
Abstract (Originalsprache)
RNA-binding proteins play diverse roles in cancer, influencing various facets of the disease, including proliferation, apoptosis, angiogenesis, senescence, invasion, epithelial–mesenchymal transition (EMT), and metastasis. HuR, a known RBP, is recognized for stabilizing mRNAs containing AU-rich elements (AREs), although its complete repertoire of mRNA targets remains undefined. Through a bioinformatics analysis of the gene expression profile of the Hs578T basal-like triple-negative breast cancer cell line with silenced HuR, we have identified SOX9 as a potential HuR-regulated target. SOX9 is a transcription factor involved in promoting EMT, metastasis, survival, and the maintenance of cancer stem cells (CSCs) in triple-negative breast cancer. Ribonucleoprotein immunoprecipitation assays confirm a direct interaction between HuR and SOX9 mRNA. The half-life of SOX9 mRNA and the levels of SOX9 protein decreased in cells lacking HuR. Cells silenced for HuR exhibit reduced migration and invasion compared to control cells, a phenotype similar to that described for SOX9-silenced cells.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento de Bioquímica UAM, Instituto de Investigaciones Biomédicas Sols-Morreale, CSIC-UAM, 28029 Madrid, Spain.
- Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28029 Madrid, Spain.
- Fundación MD Anderson Internacional, 28033 Madrid, Spain.
- Instituto de Investigación Sanitaria del Hospital Universitario La Paz-IdiPAZ, 28029 Madrid, Spain.
- Centro de Investigación Biomédica en Red, Área de Cáncer (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.
ORCID-Profile: Jesús Morillo-Bernal, Gema Moreno-Bueno
Förderung
- Spanish Ministry of Science and Innovation SAF2016-76504-R (A.C. and F.P.)
- EU-FEDER funds
Zitieren
APA
Morillo-Bernal, J., Pizarro-García, P., Moreno-Bueno, G., Cano, A., Mazón, M. J., Eraso, P., & Portillo, F. (2024). HuR (ELAVL1) Stabilizes SOX9 mRNA and Promotes Migration and Invasion in Breast Cancer Cells. Cancers, 16(2), 384. https://doi.org/10.3390/cancers16020384
Vancouver
Morillo-Bernal J, Pizarro-García P, Moreno-Bueno G, Cano A, Mazón MJ, Eraso P, et al. HuR (ELAVL1) Stabilizes SOX9 mRNA and Promotes Migration and Invasion in Breast Cancer Cells. Cancers. 2024;16(2):384. doi:10.3390/cancers16020384
BibTeX
@article{MorilloBernal2024,
author = {Morillo-Bernal, Jesús and Pizarro-García, Patricia and Moreno-Bueno, Gema and Cano, Amparo and Mazón, María J and Eraso, Pilar and Portillo, Francisco},
title = {HuR (ELAVL1) Stabilizes SOX9 mRNA and Promotes Migration and Invasion in Breast Cancer Cells},
journal = {Cancers},
year = {2024},
volume = {16},
number = {2},
pages = {384},
doi = {10.3390/cancers16020384}
}
EUVIMED